METHOD FOR PREDICTING COURSE OF DISEASE IN PATIENTS WITH NON-HODGKIN B-CELL LYMPHOMA FROM SMALL LYMPHOCYTES

• 1. 从非霍奇金淋巴瘤细胞系中鉴定、分离、培养淋巴瘤干细胞的方法 [P] . 中国专利： CN107354135A . 2017-11-17
• 2. 利用噻吩并三唑并二氮杂*化合物治疗耐受性非霍奇金淋巴瘤、髓母细胞瘤和/或ALK+非小细胞肺癌的方法 [P] . 中国专利： CN106687117A . 2017-05-17
• 3. METHOD FOR PREDICTING OF DISEASE COURSE IN PATIENTS WITH NON-HODGKIN DIFFUSION B-LARGE-CELL LYMPHOMAS [P] . UA85576U . 2013-11-25

  机译： 非霍奇金扩散性B细胞淋巴瘤患者疾病过程的预测方法

• 4. A method for predicting the risk of progression of primary B-cell non-Hodgkin lymphomas with bone marrow damage [P] . 俄罗斯专利： RU2016109522A . 2017-09-21

  机译： 预测原发性B细胞非霍奇金淋巴瘤并发骨髓损伤的风险的方法

• 5. METHOD FOR IMMUNOCYTOCHEMICAL DETERMINATION OF PATHOLOGICAL B-CELLS IN THE BONE MARROW AND BLOOD OF PATIENTS WITH NON-HODGKIN LYMPHOMA [P] . UA98909U . 2015-05-12

  机译： 非霍奇金淋巴瘤患者血液及骨髓中病理B细胞的免疫细胞化学测定方法

• 1. R-CHOP regimen can significantly decrease the risk of disease relapse and progression in patients with non-germinal center B-cell subtype diffuse large B-cell lymphoma [J] . Xiao-Hui He, Mei Dong, Sheng-Yu Zhou, 癌症（英文版） . 2012,第006期
• 2. Absolute lymphocyte count predicts response to rituximab-containing salvage treatment for relapsed/refractory B-cell non-Hodgkin's lymphoma with prior rituximab exposure [J] . Man-Hsin Hung, Yuan-Bin Yu, Liang-Tsai Hsiao, Journal of the Chinese Medical Association: JCMA . 2013,第4期
• 3. CNS disease in younger patients with aggressive B-cell lymphoma: An analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group [J] . SchmitzN., ZeynalovaS., GlassB., Annals of oncology: official journal of the European Society for Medical Oncology . 2012,第5期
• 4. CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera Internationaln Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group [J] . M. Pfreundschuh Annals of Oncology . 2012,第5期
• 5. Machine learning methods to predict presence of intestine damage in patients with Crohn's disease [C] . Binu E. Enchakalody, Brianna Henderson, Stewart C. Wang, Medical Imaging Conference . 2020
• 6. Regulation of CD20 in rituximab-resistant cell lines (RRCL) and B-cell non-Hodgkin's lymphoma (B-NHL) [D] . Tsai, Ping-Chiao 2012
• 7. SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target [O] . Dale J. Christensen, Youwei Chen, Jessica Oddo, -1
• 8. Absolute lymphocyte count predicts response to rituximab-containing salvage treatment for relapsed/refractory B-cell non-Hodgkin's lymphoma with prior rituximab exposure [O] . Man-Hsin Hung, Yuan-Bin Yu, Liang-Tsai Hsiao, 2013

• 1. The Lower Peripheral Blood Lymphocyte to Monocyte Ratio Following Completion of First Line Chemotherapy Is a Risk Factor for Predicting Relapse in Patients with Diffuse Large B-Cell Lymphoma [J] . Ghada Ezzat Eladawei ,Sheref Mohamed El-Taher . 癌症治疗（英文） . 2019,第1期
• 2. Rituximab Improves Overall Survival in Patients Treated with CODOX-M/IVAC for Burkitt Lymphoma (BL) and B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and BL (BCL-U): A Single Center Experience and Review of the Literature [J] . A. Prica ,A. Pratzer ,M. Cheung . 癌症治疗（英文） . 2015,第1期
• 3. Recent advances in post autologous transplantation maintenance therapies in B-cell non-Hodgkin lymphomas [J] . Narendranath Epperla ,Timothy S Fenske ,Parameswaran N Hari . 世界移植杂志 . 2015,第3期
• 4. Unusual Presentation of Non-Hodgkin’s B-Cell Lymphoma with Unilateral Right Limb Lymphedema [J] . Massimo Bolognesi ,Diletta Bolognesi . 临床医学病理报告（英文） . 2014,第11期
• 5. B淋巴细胞刺激因子对B细胞非霍奇金淋巴瘤细胞生长调控的研究 [C] . 王志彬 ,高玉环 ,刁兰萍 . 河北省医学会第五届第二次血液学年会暨河北省医师协会血液科医师分会第一届第二次大会 . 2009
• 6. 动态监测外周血淋巴细胞与单核细胞比值对非霍奇金淋巴瘤患者的疗效判断和预后指导意义 [A] . 张胜楠 . 2020